|
|
|
|
Hepatic de Novo Lipogenesis Is Elevated in
Patients With NASH Across the Spectrum of Disease Severity
|
|
|
Reported by Jules Levin
AASLD: The Liver Meeting 2017, October 20-24, 2017, Washington, DC
Eric J. Lawitz,1 Kelvin Li,2 Mark Fitch,2 Jacqueline Tarrant,3 Mona Vimal,3 Ren Xu,3 Qinghua Song,3 Raul Aguilar Schall,3
Bryan J. McColgan,3 C. Stephen Djedjos,3 Adrian S. Ray,3 Robert P. Myers,3 Marc Hellerstein,2 Rohit Loomba4
1Texas Liver Institute, UT Health San Antonio, TX; 2University of California, Berkeley; 3Gilead Sciences, Inc., Foster City, CA; 4UC San Diego, La Jolla, CA
References
1. Harriman G, et al. Proc Natl Acad Sci USA 2016;113:E1796-805; 2. Neuschwander-Tetri B, et al. Hepatology 2010;52:774-88; 3. Lambert JE, et al. Gastroenterology 2014;146:726-35;
4. Siddiqui MS, et al. Clin Gastroenterol Hepatol 2015;13:1000-8; 5. Kirby B, et al. AASLD 2017, abstr 2172; 6. Hellerstein MK, et al. Am J Physiol 192;263:E988-1001.
|
|
|
|
|
|
|